KLSE (MYR): PHARMA (7081)
You're accessing 15 mins delay data. Turn on live stream now to enjoy real-time data!
Last Price
0.28
Today's Change
-0.01 (3.45%)
Day's Change
0.275 - 0.295
Trading Volume
1,419,500
Name | Role |
---|
Biocon’s biosimilar insulin supplied by Biocon Sdn Bhd and Duopharma Sdn Bhd. MOH contract suppose to end 28 April 2025. After that Pharma would increase production 24/7 ler 😆😆!!
2 months ago
if can produce another stellar performance over $50 mil profits, than this company would be in the right direction to recover in style.
BTW, this company already start producing Human Insulin, with first batch delivery was last month, 22 January 2025.
The potential might be huge not just for local supply, but considering middle-east, Halal medication.
2 months ago
20/3/2025 will decide capital reduction RM 500m, private placement and rights issue.
2 months ago
"While the price for the rights issue is not yet set, the illustrative issue price according to Pharmaniaga’s circular to shareholders was set at 10 sen, which represents a 52.3% discount from Pharmaniaga’s last closing price of 21 sen on Tuesday.
Meanwhile, the illustrative issue price for the proposed private placement was 14 sen, reflecting a 33.3% discount from the last closing price."
RI not yet set the ratio, this kind of management totally rubbish.
No Ratio, how to vote in EGM?
Totally bullshXX management.
2 months ago
how to proceed with Capital reduction $520 million when the existing share price only 0.225 cents? ..
current value only $320 mil?? confius sekejap..any accountant could xplain the shold process??
2 months ago
this Pharma would be in much better shape from pre-Covid time with its increasing list of product for MOH, Indonesia expansion business and Halal insulin product, that is going to replace Biocon contract, which gonna expired end of April this year. TP would be 38-40 cents.
2 months ago
Let’s see how the EGM goes . Anyone has an opinion of the tabled resolutions? Good or Bad?
2 months ago
dont think so..if fall back, i will top up big at that level again..hehe. The final piece already settle, next.. exiting from PN17. In the mean time, hopefully can get good news about insulin new contract for 2025 onwards.
Those who had not accumulated, can do so at this level.
2 months ago
Good thing about this counter, no Trumph or middle east effect, once PN17 exit, baru ler fund managers able to buy. I am not surprise if EPF and other fund managers will buy this counter once PN17 lifted.
2 months ago
Seems to more ppl selling than grabbing ???? Do they know something that we all dont know ?
1 month ago
Closed at 0.245. Able to push up a bit. Let see tomorrow can still uptrend or not
1 month ago
first.. no product exported to US, second.. this will opens up more opportunities by giving the alternative for Indonesia to import more from Malaysia instead, or maybe even to Singapula also start buying form us :-)
1 month ago
Slow buying has started to pickup. Hope can slowly slowly go up back to 0.300 ++
1 month ago
Just when it starts to move up slowly.....came out announcement, material uncertainty related to going concern in respect of the financial statements for financial year ended 31 December 2024
3 weeks ago
Drops back to 0.250.....maybe will slowly return back to 0.200 ? Needs some good news to push it up again.
3 weeks ago
Up 0.305. Moving upwards slowly. Hope can go back to 52 weeks high at 0.470. Let wait and see......
1 week ago
With new announcement from Trump, Pharma see a selloff. Lucky still holding strong at 0.295.
1 week ago
Trump slashing drugs prices upto 90%.
Cheaper medical bills?
He is also planning to cut middle man or buayas.
2 days ago
Ron90
Minister: Biocon Failed Human Insulin Supply Contractual Obligations
By CodeBlue | 26 August 2024
Dr Dzul says India’s Biocon Biologics, which runs a Johor manufacturing plant, failed its human insulin supply contractual obligations. He adds the current human insulin supply can last till year end, dismissing an “alarmist” scenario of the shortage.
2 months ago